Literature DB >> 26090982

Unusual Femur Stress Fractures in Children With Osteogenesis Imperfecta and Intramedullary Rods on Long-term Intravenous Pamidronate Therapy.

Abdelsalam Hegazy1, Mohamed Kenawey, Etienne Sochett, Lianne Tile, Angela M Cheung, Andrew W Howard.   

Abstract

In this report, we describe 6 children with osteogenesis imperfecta with unusual stress femoral fractures. All children were on long-term cyclic pamidronate treatment. All fractures occurred without trauma or with minimal trauma and were located in the subtrochanteric or the diaphyseal regions of the femur over preexisting intramedullary rods. These fractures have very similar features to the reported minimal trauma atypical femoral fractures in adults on long-term bisphosphonate treatment. These fractures raise concerns about the role of prolonged remodeling suppression and microdamage accumulation and the risk of increased bone fragility.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26090982     DOI: 10.1097/BPO.0000000000000552

Source DB:  PubMed          Journal:  J Pediatr Orthop        ISSN: 0271-6798            Impact factor:   2.324


  7 in total

Review 1.  Zoledronic acid in pediatric metabolic bone disorders.

Authors:  Sasigarn A Bowden; John D Mahan
Journal:  Transl Pediatr       Date:  2017-10

Review 2.  The management of osteoporosis in children.

Authors:  L M Ward; V N Konji; J Ma
Journal:  Osteoporos Int       Date:  2016-04-28       Impact factor: 4.507

3.  An atypical fracture in male patient with osteogenesis imperfecta.

Authors:  Iñigo Etxebarria-Foronda; Pedro Carpintero
Journal:  Clin Cases Miner Bone Metab       Date:  2015-12-29

4.  A Subtrochanteric Femoral Stress Fracture following Bisphosphonate Treatment in an Adolescent Girl.

Authors:  Alison M Boyce; Michael T Collins; Laura L Tosi; Rachel I Gafni
Journal:  Horm Res Paediatr       Date:  2016-07-06       Impact factor: 2.852

Review 5.  An Evaluative History of Bisphosphonate Drugs: Dual Physiologic Effects of Pyrophosphate as Inspiration for a Novel Pharmaceutical Class.

Authors:  W Banks Hinshaw; Allyn F DeLong
Journal:  J Osteoporos       Date:  2016-10-05

6.  Skeletal outcomes of patients with osteogenesis imperfecta during drug holiday of bisphosphonates: a real-world study.

Authors:  Yongze Zhang; Jing Hu; Xiaoyun Lin; Lei Sun; Sunjie Yan; Qian Zhang; Yan Jiang; Ou Wang; Weibo Xia; Xiaoping Xing; Mei Li
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-26       Impact factor: 6.055

Review 7.  Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review.

Authors:  Hanh H Nguyen; Denise M van de Laarschot; Annemieke JMH Verkerk; Frances Milat; M Carola Zillikens; Peter R Ebeling
Journal:  JBMR Plus       Date:  2018-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.